ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis

The excision repair cross completing group 1 gene product (ERCC1) and the regulatory subunit of ribonucleotide reductase (RRM1) have been reported as being prognostic of outcome and predictive of therapeutic efficacy in patients with non–small cell lung cancer. Routinely processed surgical specimens...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bepler, Gerold, Olaussen, Ken André, Vataire, Anne-Lise, Soria, Jean-Charles, Zheng, Zhong, Dunant, Ariane, Pignon, Jean-Pierre, Schell, Michael J., Fouret, Pierre, Pirker, Robert, Filipits, Martin, Brambilla, Elisabeth
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Investigative Pathology 2011
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3069904/
https://ncbi.nlm.nih.gov/pubmed/21224045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2010.11.029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados